Recently the Philippines News Agency reported on President Roberto Duterte’s move, possibly to the chagrin of the World Health Organization (WHO), to leave the determination of what approved, off-label drugs to use with physicians and their consenting patients—the way it used to work in the United States. In this case, a presidential edict declared that this right is applicable to ivermectin as an off-label treatment for COVID-19. President Duterte’s remarks were pre-recorded in a major speech delivered to the Philippines population.
Duterte has a reputation as a strong-armed nationalist, hostility to the West aside; the Philippines president declared the use of ivermectin was a “good gamble” for those physicians and their consenting patients seeking a treatment targeting COVID-19.
Reporting for the government’s official news agency, Ruth Abbey Gita-Carlos wrote on the mounting tension in the country between most medical authorities that demand the drug only be used in a clinical trial and large numbers in civil society that have followed the dozens of clinical trials, primarily in low- and middle-income countries (LMICs). The reporter included a quote from Duterte, declarin...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).